225 related articles for article (PubMed ID: 35970849)
21. The OM-85 bacterial lysate inhibits SARS-CoV-2 infection of epithelial cells by downregulating SARS-CoV-2 receptor expression.
Pivniouk V; Pivniouk O; DeVries A; Uhrlaub JL; Michael A; Pivniouk D; VanLinden SR; Conway MY; Hahn S; Malone SP; Ezeh P; Churko JM; Anderson D; Kraft M; Nikolich-Zugich J; Vercelli D
J Allergy Clin Immunol; 2022 Mar; 149(3):923-933.e6. PubMed ID: 34902435
[TBL] [Abstract][Full Text] [Related]
22. Immunohistochemical Study of SARS-CoV-2 Viral Entry Factors in the Cornea and Ocular Surface.
Roehrich H; Yuan C; Hou JH
Cornea; 2020 Dec; 39(12):1556-1562. PubMed ID: 32826650
[TBL] [Abstract][Full Text] [Related]
23. Angiotensin-converting enzyme 2 (ACE2), SARS-CoV-2 and the pathophysiology of coronavirus disease 2019 (COVID-19).
Bourgonje AR; Abdulle AE; Timens W; Hillebrands JL; Navis GJ; Gordijn SJ; Bolling MC; Dijkstra G; Voors AA; Osterhaus AD; van der Voort PH; Mulder DJ; van Goor H
J Pathol; 2020 Jul; 251(3):228-248. PubMed ID: 32418199
[TBL] [Abstract][Full Text] [Related]
24. Age and gender differences in ACE2 and TMPRSS2 expressions in oral epithelial cells.
Peng J; Sun J; Zhao J; Deng X; Guo F; Chen L
J Transl Med; 2021 Aug; 19(1):358. PubMed ID: 34412632
[TBL] [Abstract][Full Text] [Related]
25. Estrogen regulates the expression of SARS-CoV-2 receptor ACE2 in differentiated airway epithelial cells.
Stelzig KE; Canepa-Escaro F; Schiliro M; Berdnikovs S; Prakash YS; Chiarella SE
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1280-L1281. PubMed ID: 32432918
[TBL] [Abstract][Full Text] [Related]
26. d-Galactose treatment increases ACE2, TMPRSS2, and FURIN and reduces SERPINA1 mRNA expression in A549 human lung epithelial cells.
Baristaite G; Gurwitz D
Drug Dev Res; 2022 May; 83(3):622-627. PubMed ID: 34677831
[TBL] [Abstract][Full Text] [Related]
27. COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection.
Beyerstedt S; Casaro EB; Rangel ÉB
Eur J Clin Microbiol Infect Dis; 2021 May; 40(5):905-919. PubMed ID: 33389262
[TBL] [Abstract][Full Text] [Related]
28. Impact of I/D polymorphism of angiotensin-converting enzyme 1 (ACE1) gene on the severity of COVID-19 patients.
Verma S; Abbas M; Verma S; Khan FH; Raza ST; Siddiqi Z; Ahmad I; Mahdi F
Infect Genet Evol; 2021 Jul; 91():104801. PubMed ID: 33676010
[TBL] [Abstract][Full Text] [Related]
29.
Martínez-Gómez LE; Herrera-López B; Martinez-Armenta C; Ortega-Peña S; Camacho-Rea MDC; Suarez-Ahedo C; Vázquez-Cárdenas P; Vargas-Alarcón G; Rojas-Velasco G; Fragoso JM; Vidal-Vázquez P; Ramírez-Hinojosa JP; Rodríguez-Sánchez Y; Barrón-Díaz D; Moreno ML; Martínez-Ruiz FJ; Zayago-Angeles DM; Mata-Miranda MM; Vázquez-Zapién GJ; Martínez-Cuazitl A; Barajas-Galicia E; Bustamante-Silva L; Zazueta-Arroyo D; Rodríguez-Pérez JM; Hernández-González O; Coronado-Zarco R; Lucas-Tenorio V; Franco-Cendejas R; López-Jácome LE; Vázquez-Juárez RC; Magaña JJ; Cruz-Ramos M; Granados J; Hernández-Doño S; Delgado-Saldivar D; Ramos-Tavera L; Coronado-Zarco I; Guajardo-Salinas G; Muñoz-Valle JF; Pineda C; Martínez-Nava GA; López-Reyes A
Front Immunol; 2022; 13():812940. PubMed ID: 35250987
[TBL] [Abstract][Full Text] [Related]
30. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
Cheng H; Wang Y; Wang GQ
J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms of ACE1, ACE2, IFTM3, TMPRSS2 and TNFα genes associated with susceptibility and severity of SARS-CoV-2 infection: a systematic review and meta-analysis.
Pecoraro V; Cuccorese M; Trenti T
Clin Exp Med; 2023 Nov; 23(7):3251-3264. PubMed ID: 37055652
[TBL] [Abstract][Full Text] [Related]
32. A novel ACE2 isoform is expressed in human respiratory epithelia and is upregulated in response to interferons and RNA respiratory virus infection.
Blume C; Jackson CL; Spalluto CM; Legebeke J; Nazlamova L; Conforti F; Perotin JM; Frank M; Butler J; Crispin M; Coles J; Thompson J; Ridley RA; Dean LSN; Loxham M; Reikine S; Azim A; Tariq K; Johnston DA; Skipp PJ; Djukanovic R; Baralle D; McCormick CJ; Davies DE; Lucas JS; Wheway G; Mennella V
Nat Genet; 2021 Feb; 53(2):205-214. PubMed ID: 33432184
[TBL] [Abstract][Full Text] [Related]
33. Functional and genetic analysis of viral receptor ACE2 orthologs reveals a broad potential host range of SARS-CoV-2.
Liu Y; Hu G; Wang Y; Ren W; Zhao X; Ji F; Zhu Y; Feng F; Gong M; Ju X; Zhu Y; Cai X; Lan J; Guo J; Xie M; Dong L; Zhu Z; Na J; Wu J; Lan X; Xie Y; Wang X; Yuan Z; Zhang R; Ding Q
Proc Natl Acad Sci U S A; 2021 Mar; 118(12):. PubMed ID: 33658332
[TBL] [Abstract][Full Text] [Related]
34. An improved Fuzzy based GWO algorithm for predicting the potential host receptor of COVID-19 infection.
Achom A; Das R; Pakray P
Comput Biol Med; 2022 Dec; 151(Pt A):106050. PubMed ID: 36334362
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy.
Datta PK; Liu F; Fischer T; Rappaport J; Qin X
Theranostics; 2020; 10(16):7448-7464. PubMed ID: 32642005
[TBL] [Abstract][Full Text] [Related]
36. Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole-exome sequencing data in the Turkish population.
Duman N; Tuncel G; Bisgin A; Bozdogan ST; Sag SO; Gul S; Kiraz A; Balta B; Erdogan M; Uyanik B; Canbek S; Ata P; Geckinli BB; Arslan Ates E; Alavanda C; Yesim Ozdemir S; Sezer O; Ozgon GO; Gurkan H; Guler K; Boga I; Kaya N; Alemdar A; Sayan M; Dundar M; Ergoren MC; Temel SG
J Med Virol; 2022 Nov; 94(11):5225-5243. PubMed ID: 35811452
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive analysis of two potential novel SARS-CoV-2 entries, TMPRSS2 and IFITM3, in healthy individuals and cancer patients.
Dai YJ; Zhang WN; Wang WD; He SY; Liang CC; Wang DW
Int J Biol Sci; 2020; 16(15):3028-3036. PubMed ID: 33061814
[TBL] [Abstract][Full Text] [Related]
38. Systematic analysis of ACE2 and TMPRSS2 expression in salivary glands reveals underlying transmission mechanism caused by SARS-CoV-2.
Song J; Li Y; Huang X; Chen Z; Li Y; Liu C; Chen Z; Duan X
J Med Virol; 2020 Nov; 92(11):2556-2566. PubMed ID: 32441816
[TBL] [Abstract][Full Text] [Related]
39. Integration of risk variants from GWAS with SARS-CoV-2 RNA interactome prioritizes FUBP1 and RAB2A as risk genes for COVID-19.
Shi W; Chen M; Pan T; Chen M; Cheng Y; Hao Y; Chen S; Tang Y
Sci Rep; 2023 Nov; 13(1):19194. PubMed ID: 37932299
[TBL] [Abstract][Full Text] [Related]
40. Type 2 and interferon inflammation regulate SARS-CoV-2 entry factor expression in the airway epithelium.
Sajuthi SP; DeFord P; Li Y; Jackson ND; Montgomery MT; Everman JL; Rios CL; Pruesse E; Nolin JD; Plender EG; Wechsler ME; Mak ACY; Eng C; Salazar S; Medina V; Wohlford EM; Huntsman S; Nickerson DA; Germer S; Zody MC; Abecasis G; Kang HM; Rice KM; Kumar R; Oh S; Rodriguez-Santana J; Burchard EG; Seibold MA
Nat Commun; 2020 Oct; 11(1):5139. PubMed ID: 33046696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
